IL1B and ulcer disease: These effects are mediated through the suppression of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β), as well as the promotion of ulcer healing and epithelial regeneration [4].